|
1
|
National Lung Screening Trial Research
Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom
RM, Gareen IF, Gatsonis C, Marcus PM and Sicks JD: Reduced
lung-cancer mortality with low-dose computed tomographic screening.
N Engl J Med. 365:395–409. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gohagan JK, Marcus PM, Fagerstrom RM,
Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B,
Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E,
Gierada D, Hocking W, Inampudi S, Irons B, Johnson CC, Jones A,
Kucera G, Kvale P, Lappe K, Manor W, Moore A, Nath H, Neff S, Oken
M, Plunkett M, Price H, Reding D, Riley T, Schwartz M, Spizarny D,
Yoffie R and Zylak C; Lung Screening Study Research Group: Final
results of the Lung Screening Study, a randomized feasibility study
of spiral CT versus chest X-ray screening for lung cancer. Lung
Cancer. 47:9–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Henschke CI, Naidich DP, Yankelevitz DF,
McGuinness G, McCauley DI, Smith JP, Libby D, Pasmantier M, Vazquez
M, Koizumi J, Flieder D, Altorki N and Miettinen OS: Early lung
cancer action project: initial findings on repeat screenings.
Cancer. 92:153–159. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McWilliams A, Mayo J, MacDonald S, LeRiche
JC, Palcic B, Szabo E and Lam S: Lung cancer screening: a different
paradigm. Am J Respir Crit Care Med. 168:1167–1173. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goulart BH, Bensink ME, Mummy DG and
Ramsey SD: Lung cancer screening with low-dose computed tomography:
costs, national expenditures, and cost-effectiveness. J Natl Compr
Canc Netw. 10:267–275. 2012.PubMed/NCBI
|
|
6
|
Chen W, Gao X, Tian Q and Chen L: A
comparison of autofluorescence bronchoscopy and white light
bronchoscopy in detection of lung cancer and preneoplastic lesions:
a meta-analysis. Lung Cancer. 73:183–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bota S, Auliac JB, Paris C, Métayer J,
Sesboüé R, Nouvet G and Thiberville L: Follow-up of bronchial
precancerous lesions and carcinoma in situ using fluorescence
endoscopy. Am J Respir Crit Care Med. 164:1688–1693. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lam S, Kennedy T, Unger M, Miller YE,
Gelmont D, Rusch V, Gipe B, Howard D, LeRiche JC, Coldman A and
Gazdar AF: Localization of bronchial intraepithelial neoplastic
lesions by fluorescence bronchoscopy. Chest. 113:696–702. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lam S and Palcic B: Re: Autofluorescence
bronchoscopy in the detection of squamous metaplasia and dysplasia
in current and former smokers. J Natl Cancer Inst. 91:561–562.
1999. View Article : Google Scholar
|
|
10
|
Loewen G, Natarajan N, Tan D, Nava E,
Klippenstein D, Mahoney M, Cummings M and Reid M: Autofluorescence
bronchoscopy for lung cancer surveillance based on risk assessment.
Thorax. 62:335–340. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fleischhacker M and Schmidt B: Free
circulating nucleic acids in plasma and serum (CNAPS) - Useful for
the detection of lung cancer patients? Cancer Biomark. 6:211–219.
2010.PubMed/NCBI
|
|
12
|
Paci M, Maramotti S, Bellesia E, Formisano
D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D,
Carbonelli C, De Franco S, Brini M, Sgarbi G and Lodi R:
Circulating plasma DNA as diagnostic biomarker in non-small cell
lung cancer. Lung Cancer. 64:92–97. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sozzi G, Conte D, Mariani L, Lo Vullo S,
Roz L, Lombardo C, Pierotti MA and Tavecchio L: Analysis of
circulating tumor DNA in plasma at diagnosis and during follow-up
of lung cancer patients. Cancer Res. 61:4675–4678. 2001.PubMed/NCBI
|
|
14
|
Sozzi G, Conte D, Leon M, Ciricione R, Roz
L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA
and Pastorino U: Quantification of free circulating DNA as a
diagnostic marker in lung cancer. J Clin Oncol. 21:3902–3908. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Szpechcinski A, Dancewicz M, Kopinski P,
Kowalewski J and Chorostowska-Wynimko J: Real-time PCR
quantification of plasma DNA in non-small cell lung cancer patients
and healthy controls. Eur J Med Res. 14(Suppl 4): 237–240. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van Boerdonk RA, Sutedja TG, Snijders PJ,
Reinen E, Wilting SM, van de Wiel MA, Thunnissen FE, Duin S, Kooi
C, Ylstra B, Meijer CJ, Meijer GA, Grünberg K, Daniels JM, Postmus
PE, Smit EF and Heideman DA: DNA copy number alterations in
endobronchial squamous metaplastic lesions predict lung cancer. Am
J Respir Crit Care Med. 184:948–956. 2011.PubMed/NCBI
|
|
17
|
Sobin LH and Wittekind C: TNM
Classification of Malignant Tumours. 6th edition. Wiley-Liss; New
York, NY: 2002
|
|
18
|
Travis WD, Brambilla E, Muller-Hermelink
KM and Harris CC: World Health Organization Classification of
Tumours: Pathology and Genetics of Tumours of the Lung, Pleura,
Thymus and Heart. IARC Press; Lyon: 2004
|
|
19
|
de Wilde J, De-Castro AJ, Snijders PJ,
Meijer CJ, Rösl F and Steenbergen RD: Alterations in AP-1 and AP-1
regulatory genes during HPV-induced carcinogenesis. Cell Oncol.
30:77–87. 2008.PubMed/NCBI
|
|
20
|
Hesselink AT, van den Brule AJ,
Groothuismink ZM, Molano M, Berkhof J, Meijer CJ and Snijders PJ:
Comparison of three different PCR methods for quantifying human
papillomavirus type 16 DNA in cervical scrape specimens. J Clin
Microbiol. 43:4868–4871. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roz L, Verri C, Conte D, Miceli R, Mariani
L, Calabro’ E, Andriani F, Pastorino U and Sozzi G: Plasma DNA
levels in spiral CT-detected and clinically detected lung cancer
patients: a validation analysis. Lung Cancer. 66:270–271. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sozzi G, Roz L, Conte D, Mariani L,
Andriani F, Lo Vollo S, Verri C and Pastorino U: Plasma DNA
quantification in lung cancer computed tomography screening:
five-year results of a prospective study. Am J Respir Crit Care
Med. 179:69–74. 2009.PubMed/NCBI
|
|
23
|
Shukla D, Kale AD, Hallikerimath S,
Yerramalla V and Subbiah V: Can quantifying free-circulating DNA be
a diagnostic and prognostic marker in oral epithelial dysplasia and
oral squamous cell carcinoma? J Oral Maxillofac Surg. Jun 29–2012,
(Epub ahead of print).
|
|
24
|
Nakamura T, Sueoka-Aragane N, Iwanaga K,
Sato A, Komiya K, Kobayashi N, Hayashi S, Hosomi T, Hirai M, Sueoka
E and Kimura S: Application of a highly sensitive detection system
for epidermal growth factor receptor mutations in plasma DNA. J
Thorac Oncol. 7:1369–1381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Breuer RH, Pasic A, Smit EF, van Vliet E,
Vonk Noordegraaf A, Risse EJ, Postmus PE and Sutedja TG: The
natural course of preneoplastic lesions in bronchial epithelium.
Clin Cancer Res. 11(2 Pt 1): 537–543. 2005.PubMed/NCBI
|
